Aug 30, 2011
Patent Expiries and Generic Competition Are Negatively Impacting upon the Market, Reducing its CAGR from 7.7% in 2002-2010 to 3.1% in 2010-2017
Aug 30, 2011
CVD is One of the Four Major Therapeutic Areas for Clinical Trials.
Aug 30, 2011
The Highest Number of Trials Were Conducted in Schizophrenia, in Terms of Trials Conducted for CNS from 2000-2009
Aug 30, 2011
Licensing – A Major Growth Driver for the Pharmaceutical Industry
Aug 26, 2011
The global gastrointestinal disorder therapeutics market is projected to generate revenues of approximately $18.3 billion by 2017, after declining at a CAGR (Compounded Annual Growth Rate) of -4.8% during the period 2010-2017
Aug 26, 2011
The Number of Clinical Trials Conducted for Rheumatoid Arthritis was the Highest of all the Autoimmune Disorders
Aug 26, 2011
Moderate Growth Rate and Increasing Competition for the Therapeutic Proteins Market
Aug 19, 2011
Exxon Mobil Benefiting From Large Scale of Operations to Reach Top Ranking
Jul 28, 2011
Emerging Technologies Such as Drug-eluting Balloons and MRI Compatible Pacemakers to have Substantial Impact on the Cardiovascular Devices Market
Jul 20, 2011
Increasing Demand for Tablet PCs Will Boost Sales of IC Manufacturers